Skip to main content

Table 3 Determination of the minimal clinically important difference in PROMIS PF20a scores

From: Validation of the Patient-Reported Outcomes Measurement Information System (PROMIS®) physical function questionnaire in late-onset Pompe disease using PROPEL phase 3 data

Subject’s global impression of change in overall well-being between 0 and 52 weeks

Number of patients (%)

Change in PROMIS PF20a from 0 to 52 weeks, mean (SD)

1: very much worse

0 (0.0)

N/A

2: much worse

4 (3.4)

-2.8 (7.9)

3: somewhat worse

19 (16.2)

-3.4 (7.5)

4: no change

45 (38.5)

2.2 (10.0)

5: somewhat improved

36 (30.8)

2.4 (6.7)

6: much improved

8 (6.8)

4.4 (5.1)

7: very much improved

5 (4.3)

8.5 (11.9)

  1. PROMIS PF20a: Patient-Reported Outcome Measurement Information System Physical Function short form 20a; SD: standard deviation